These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 28286270
1. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway. Cai J, Liu T, Huang P, Yan W, Guo C, Xiong L, Liu A. Biochem Biophys Res Commun; 2017 Apr 22; 486(1):184-190. PubMed ID: 28286270 [Abstract] [Full Text] [Related]
2. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation. Zhu J, Lv J, Chen J, Zhang X, Ji Y. Cell Cycle; 2020 Nov 22; 19(21):2851-2865. PubMed ID: 33064959 [Abstract] [Full Text] [Related]
3. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma. Zhao Y, Zhang B, Lei Y, Sun J, Zhang Y, Yang S, Zhang X. Tumour Biol; 2016 Oct 22; 37(10):13167-13176. PubMed ID: 27456357 [Abstract] [Full Text] [Related]
4. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance. Wang L, Chen T, Li X, Yan W, Lou Y, Liu Z, Chen H, Cui Z. Int J Oncol; 2019 Jul 22; 55(1):277-288. PubMed ID: 31180526 [Abstract] [Full Text] [Related]
5. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2. Chen X, Hao B, Han G, Liu Y, Dai D, Li Y, Wu X, Zhou X, Yue Z, Wang L, Cao Y, Liu J. J Cell Biochem; 2015 Feb 22; 116(2):225-32. PubMed ID: 25160587 [Abstract] [Full Text] [Related]
6. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR. Wei W, Liu Y, Lu Y, Yang B, Tang L. J Cell Biochem; 2017 Oct 22; 118(10):3349-3358. PubMed ID: 28295543 [Abstract] [Full Text] [Related]
7. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo. Yuan X, Sun X, Shi X, Jiang C, Yu D, Zhang W, Guan W, Zhou J, Wu Y, Qiu Y, Ding Y. Oncol Rep; 2015 Aug 22; 34(2):823-32. PubMed ID: 26081192 [Abstract] [Full Text] [Related]
8. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S, Li X, Niu Y, Zhu S, Jin Y, Deng S, Chen J, Liu Y, He C, Yin T, Yang Z, Tao J, Xiong J, Wu H, Wang C, Zhao G. Oncotarget; 2015 Nov 24; 6(37):39661-75. PubMed ID: 26498682 [Abstract] [Full Text] [Related]
9. USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. Gu Z, Lin C, Hu J, Xia J, Wei S, Gao D. Biol Pharm Bull; 2019 Apr 01; 42(4):573-579. PubMed ID: 30686807 [Abstract] [Full Text] [Related]
10. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway. Li M, Guo H, Wang Q, Chen K, Marko K, Tian X, Yang Y. Cancer Lett; 2020 Oct 10; 490():20-30. PubMed ID: 32585413 [Abstract] [Full Text] [Related]
11. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis. Yuan J, Li X, Zhang G, Cheng W, Wang W, Lei Y, Ma Q, Song G. Mol Carcinog; 2021 Apr 10; 60(4):265-278. PubMed ID: 33634905 [Abstract] [Full Text] [Related]
12. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1. Zhou B, Sun C, Hu X, Zhan H, Zou H, Feng Y, Qiu F, Zhang S, Wu L, Zhang B. Cell Physiol Biochem; 2017 Apr 10; 44(5):1867-1881. PubMed ID: 29224010 [Abstract] [Full Text] [Related]
13. Orai1, a Direct Target of microRNA-519, Promotes Progression of Colorectal Cancer via Akt/GSK3β Signaling Pathway. Deng W, Wang J, Zhang J, Cai J, Bai Z, Zhang Z. Dig Dis Sci; 2016 Jun 10; 61(6):1553-60. PubMed ID: 26792278 [Abstract] [Full Text] [Related]
14. Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitro. Lin Z, Xiong L, Lin Q. Mol Cell Biochem; 2016 Nov 10; 422(1-2):97-107. PubMed ID: 27629785 [Abstract] [Full Text] [Related]
15. MiR-1271 negatively regulates AKT/MTOR signaling and promotes apoptosis via targeting PDK1 in pancreatic cancer. Xie F, Huang Q, Liu CH, Lin XS, Liu Z, Liu LL, Huang DW, Zhou HC. Eur Rev Med Pharmacol Sci; 2018 Feb 10; 22(3):678-686. PubMed ID: 29461595 [Abstract] [Full Text] [Related]
16. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway. Fu Y, Yao N, Ding D, Zhang X, Liu H, Ma L, Shi W, Zhu C, Tang L. J Cell Physiol; 2020 Mar 10; 235(3):2761-2775. PubMed ID: 31531884 [Abstract] [Full Text] [Related]
17. USP39 regulates the cell cycle, survival, and growth of human leukemia cells. Liu C, Yao X, Li M, Xi Y, Zhao L. Biosci Rep; 2019 Apr 30; 39(4):. PubMed ID: 30898977 [Abstract] [Full Text] [Related]
18. Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway. Yuan J, Zhang G, Li X, Ma Q, Cheng W, Wang W, Zhang B, Hu T, Song G. Int J Mol Sci; 2020 Nov 25; 21(23):. PubMed ID: 33255748 [Abstract] [Full Text] [Related]
19. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Gao S, Wang P, Hua Y, Xi H, Meng Z, Liu T, Chen Z, Liu L. Oncotarget; 2016 Jan 12; 7(2):1608-18. PubMed ID: 26636540 [Abstract] [Full Text] [Related]
20. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway. Yu SH, Zhang CL, Dong FS, Zhang YM. J Cell Biochem; 2015 Feb 12; 116(2):268-76. PubMed ID: 25187230 [Abstract] [Full Text] [Related] Page: [Next] [New Search]